FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:2578-2579 June 11, 2009 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Fanta, C. H. PubMed Citation

To the Editor: In his review of drug therapy for asthma, Fanta (March 5 issue)¹ begins by reviewing the dramatic increase in morbidity associated with asthma in the United States during the 1970s and 1980s and the more recent improvement in asthma outcomes. However, there was no mention of the marked racial, ethnic, and socioeconomic disparities in asthma outcomes that are partly related to drug-treatment barriers.

Asthma outcomes are worse in minority and low-income populations than in nonminority and middle- and high-income populations.² The underuse of controller medications in children receiving Medicaid is much more common among Hispanic children (44%) . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.